ArticleLeukemia2018

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.

Mona M Hosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.